Year: 2021

OMAHA, Neb., Nov. 04, 2021 (GLOBE NEWSWIRE) — On November 4, 2021, America First Multifamily Investors, L.P. (NASDAQ: ATAX) (the “Partnership” or “ATAX”) announced financial results for the three and nine months ended September 30, 2021. Financial Highlights As of and for the three months ended September 30, 2021:Total revenues of $17.7 million Net income, basic and diluted, of $0.19 per Beneficial Unit Certificate (“BUC”) Cash Available for Distribution (“CAD”) of $0.22 per BUC Total assets of $1.3 billion Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”) investments of $909.6 millionFor the nine months ended September 30, 2021:Total revenues of approximately $48.5 million Net income, basic and diluted, of $0.42 per BUC Cash Available for Distribution of $0.50 per BUCThe Partnership reported the...

The decision to increase collaboration was made by the Company’s Board following the successful validation study conducted in the field by Dr. Jim Adaskaveg, a key opinion leader and professor at the University of California TEL AVIV, Israel, Nov. 04, 2021 (GLOBE NEWSWIRE) — Save Foods (Nasdaq: SVFD) (“Save Foods” or the “Company”), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced that following the completion of several successful field trials of Save Foods’ pre-harvest products conducted by Dr. Jim Adaskaveg, Professor at the Microbiology and Plant Pathology Department at the University of California, Riverside, the Board of Directors of the Company approved increased collaboration...

Next Generation Capecitabine inhibited DPD activity 24-48 hours after PCS6422 administration with < 10% of 5-FU metabolized to FBAL compared to 80% reported for FDA approved capecitabine. 24-48 hours after PCS6422 administration, 5-FU potency based on systemic exposure per mg of capecitabine was at least 50 x greater than reported for FDA approved capecitabine. The improved metabolism profile and increased potency did not exist 7 days after PCS6422 administration. The timeline of DPD inhibition and de novo formation will be further evaluated in the existing study in order to identify PCS6422 regimens which may inhibit DPD throughout capecitabine dosing.HANOVER, MD, Nov. 04, 2021 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing...

Company Announcement Copenhagen, 4 November 2021 No. 24/2021 ISS A/S (ISS.CO, ISS DC, ISSDY), a leading workplace experience and facility management company, has scheduled the release of its financial results and its Annual General Meeting on the following dates in 2022:   24 February 2022                  Annual Report 20217 April 2022                           Annual General Meeting3 May 2022                           Trading Update for Q1 202211 August 2022                     Interim Report for H1 20223 November 2022                 Trading Update for Q3 2022 ISS A/S expects to release the financial results 07.30am (CET) on the dates indicated. Any shareholder who has a proposal concerning specific business to be transacted at the Annual General Meeting on Thursday 7 April 2022 must submit such proposal(s) in writing to the Corporate...

Key Leaders from HOBO to Join Evolve’s Management Team Evolve to Invest $600 Million in Construction of Initial Renewable Fuels Project HOUSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) — Evolve Transition Infrastructure LP (“Evolve”) (NYSE American: SNMP), a publicly traded limited partnership focused on the acquisition, development and ownership of infrastructure critical to the transition of energy supply to lower carbon sources, and HOBO Renewable Diesel, LLC (“HOBO”), a renewable fuel project developer, today announced an agreement for Evolve to fund the construction of HOBO’s initial project that is expected to produce more than 120 million gallons of renewable fuels annually (the “Fuels Project”).   In furtherance of the Fuels Project and to support Evolve’s energy transaction focus, key members of the HOBO leadership team will join...

Firas M. Rahhal, MD, will present Phase 3 pivotal data from the NORSE TWO registration trial on Saturday, November 13, 2021 ISELIN, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced that Firas M. Rahhal, MD, Retina-Vitreous Associates Medical Group, Assoc. Clinical Professor of Ophthalmology, UCLA School of Medicine, will present safety and efficacy data from Outlook Therapeutics’ Phase 3 pivotal NORSE TWO trial for ONS-5010 / LYTENAVA™ (bevacizumab-vikg), an investigational ophthalmic formulation of bevacizumab for use in retinal indications. Dr. Rahhal will present the data in an oral presentation at the Retina Subspecialty Day of...

Vera Bradley + Peanuts CollectionThe Vera Bradley + Peanuts collection features three limited-edition patterns – “Ski Slope Snoopy,” “Snoopy Fair Isle” and “Ski Jump Snoopy” – and is available now in all Vera Bradley Full Line Stores, in select Vera Bradley Factory locations and online at verabradley.com.Vera Bradley + Peanuts CollectionThe Vera Bradley + Peanuts collection features three limited-edition patterns – “Ski Slope Snoopy,” “Snoopy Fair Isle” and “Ski Jump Snoopy” – and is available now in all Vera Bradley Full Line Stores, in select Vera Bradley Factory locations and online at verabradley.com.FORT WAYNE, Ind., Nov. 04, 2021 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA; “Vera Bradley” or the “Company”), a leading American bag and luggage company and iconic lifestyle brand, today...

CALABASAS, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, will hold a conference call on Thursday, November 11, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fiscal first quarter ended September 30, 2021. Financial results will be issued in a press release prior to the call. NETSOL management will host the presentation, followed by a question-and-answer period. Date: Thursday, November 11, 2021Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-Free Dial-In: 877-407-0789International Dial-In: 201-689-8562 Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty...

Acquisition of Secure Voice Corp. Provides Additional Recurring Revenue Stream and Nearly 200 Channel Partners. BATAVIA, Ill., Nov. 04, 2021 (GLOBE NEWSWIRE) —  High Wire Networks Inc. (the “Company” or “High Wire”) (OTCQB: SGSI), a global provider of technical, professional, electrical and cybersecurity services, announced today the Company has finalized its agreement to acquire the business of Secure Voice Corp. (SVC), a wholesale network services provider with facilities in the Northeast and carrying traffic across the United States. SVC’s network carries voice over IP (VoIP) and data traffic for service providers. The purchase was accomplished through a combination of cash, assumption of debt, and stock valued between $6.5 million and $9 million. This transaction is expected to be accretive to High Wire immediately....